DDI-DrugBank.d618.s0 >> The interaction of Retavase    with other cardioactive drugs has not been studied. >> 19-26
DDI-DrugBank.d618.s1 >> In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy. >> 40-46,52-72,119-125,128-139,146-154,225-232
